Burnout among physicians is only getting worse, but there are ways an organization can put a program in place to address or even prevent burnout, said James Grayson, administrative chief of staff at West Cancer Center.
Burnout among physicians is only getting worse, but there are ways an organization can put a program in place to address or even prevent burnout, said James Grayson, administrative chief of staff at West Cancer Center.
Transcript
Does burnout usually differ among clinicians in oncology compared with clinicians in other disease states?
This is going to sound a lot like the sequel to an old spaghetti Western, and it’s the good, the bad, the ugly, and the uglier. The good is, in Medscape’s most recent survey oncologists typically fell in the lowest quarter of physicians that report burnout. The bad is that it’s still near 50%. From there, the ugly is that every specialty has increased fairly dramatically since their previous survey, which was in 2013. So clearly the problem has worsened.
For oncologists, in particular, and this is maybe the part that troubles me the most, is that those that do report burnout, report a higher level of severity. And what that tells me is that oncologists walk along a very steep cliff. And if they were to fall into the traps of burnout, which is growing more and more likely, it can be pretty severe and difficult to climb back out of. And that’s not good for them, that’s not good for patients, and that’s not good for the organization that they work in. It’s very concerning and I wouldn’t let the false hope of being in the bottom quarter make us feel better.
What are some of the tell-tale signs that a physician is nearing burnout and how would you intervene?
Unfortunately, physicians are now on the other side of the coin in this case. They’re the patient. And just like other patients, they present in many different ways. Certainly, the heavy hitters of depression and frustration and a lack of job satisfaction, unhappiness—all of those do present themselves fairly consistently once you get far enough in, but that’s once burnout has already taken hold. What you want to look for is the things that help prevent you from getting to the bottom of the cliff. And in that regard, there’s as many presentations as there are physicians, because they are all individual humans and present differently.
I think one of the best ways I have seen for organizations to be able to intervene a little earlier is to create a mechanism, usually involves an individual—I actually recommend a nonclinician, like myself—that is charged with developing a credible, robust relationship with providers; checks in with them on a regular basis. What I found is that creates a nonthreatening environment for them to be honest and truthful, earlier, then maybe they would be otherwise. That person then has to take care of that information and certainly make sure that it is never weaponized or turned into anything that could be detrimental to a provider, but to take it back to the organization and work alongside the organization to prevent getting to that level of depression or anger or frustration or, at some point, some give up their profession that they’ve loved for so long. And that’s a huge loss for everybody, but most especially for them.
Could On-Body Delivery of Isatuximab Bring More Competition to Anti-CD38 Myeloma Treatment?
June 6th 2025Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration. Patients overwhelmingly preferred the hands-free delivery option.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Zanubrutinib Shows Durable Benefit for High-Risk CLL/SLL at 5 Years in SEQUOIA Trial
June 6th 2025Zanubrutinib showed long-term efficacy in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and deletion of the 17p chromosome, with progression-free survival similar to patients without high-risk disease characteristics.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Real-World Data Support Luspatercept vs ESAs for Anemia in Lower-Risk MDS
June 5th 2025Patients with myelodysplastic syndrome (MDS) who received luspatercept showed greater hemoglobin gains and transfusion independence compared with erythropoiesis-stimulating agents (ESAs) in a real-world analysis.
Read More
At EHA 2025, Hematology Discussions Will Stretch Across Lifespans and Locations
June 5th 2025The 2025 European Hematology Association (EHA) Congress, convening virtually and in Milan, Italy, from June 12 to June 15, 2025, will feature a revamped program structure for the meeting’s 30th anniversary while maintaining ample opportunities to network, debate, and absorb practice-changing findings in hematology and oncology.
Read More